NCT05415527Completed
Evaluation of Pretreatment Sarcopenia in Patients With Inoperable High-grade Ovarian Carcinoma as Part of Optimised Management
Source: ClinicalTrials.gov · Last updated 13 Oct 2026
Brief summary (registry, in English)
Prospective, monocentric study evaluating the presence of sarcopenia prior to neoadjuvant chemotherapy and during chemotherapy as part of optimised management.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 25 (actual)
- First submitted
- 7 Jun 2022
- Start date
- 11 Jun 2022
- Primary completion date
- 30 Apr 2025
- Lead sponsor
- Institut Bergonié
- Diseases
- Ovarian cancer
- NCT number
- NCT05415527
What you commit to
- Study type: Interventional
- Participants enrolled: 25
- From 11 Jun 2022 to the primary completion date, 30 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Patients over the age of 70 the G8 of whom requires oncogeriatric surgery.
Other
- Contraindication to CT-scans.
- Contraindication to bone mineral densitometry.
- Patients under guardianship, vulnerable patients or patients under any other legal protection measures.
- Geographic, social or psychological factors meaning the patient is unable to commit to study follow-up and procedures.
- Patient already included in this study or in another study evaluating the impact of sarcopenia.
Who the study is looking for
- Age ≥ 18 years.
- Inoperable, high-grade, epithelial ovarian carcinoma requiring perioperative chemotherapy (neoadjuvant and adjuvant).
- Optical medical treatment (carboplatin-taxol chemotherapy every 3 weeks) and surgery at Institut Bergonié.
- Non-clinically undernourished patient, i.e. without loss of more than 10% bodyweight in 6 months
- Free, informed and written consent signed by the participant and the investigator (on the day of inclusion at the latest and before any tests required for the research).
- Patient with social security cover in accordance with Article 1121-11 of the French code of public health.
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institut Bergonie Coordinator of this site? Confirm its status | Bordeaux | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.